CIK 0001100682 · Large accelerated filer
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Sign in to watch- Ticker
- CRL
- Exchange
- NYSE
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 27
- Entity type
- operating
- EIN
- 061397316
- Phone
- 781-222-6000
- Business address
- 251 BALLARDVALE ST, WILMINGTON, MA, 01887
- Former names
- CHARLES RIVER LABORATORIES INTERNATIONAL INC, CHARLES RIVER LABORATORIES HOLDINGS INC
- 4 Open-market sale EVP, Corp Strategy & Develop sold 400 shares at $163.72 ($65,488)
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Executive or director change
- 8-K Event Regulation FD disclosure
- 8-K Event Other events
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Grant or award CSVP, CAO, Interim CFO acquired 2,926 shares (grant or award)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K/A Event Executive or director change
- 8-K Event Executive or director change · Regulation FD disclosure
- 144 Insider Sale of Securities
- 4 Open-market sale EVP, Corp Strategy & Develop sold 800 shares at $157.60 ($126,080)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Open-market sale EVP, Corp Strategy & Develop sold 400 shares at $150.04 ($60,016)
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
Page 6 of 123 · 2,446 filings